Linde PLC (LIN) Stock Price Today
Aura AI Summary
Key Stats
- $244.95BMarket Cap
- -Volume
- Basic MaterialsSector
- $546.6452W High
- $389.3852W Low
- -Typical Hold Time
- $267.30BEnterprise Value
- 1.21%Div Yield
- -Trading Activity
Track Linde PLC (LIN) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Linde PLC has traded between a low of $389.38 and a high of $546.64, highlighting its annual price range. Buy and sell Linde PLC shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Linde PLC
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $31 billion in revenue and $5 billion in GAAP operating profit in 2021.
Most Recent News
Software Defined Vehicle market to grow from $447.55B in 2026 to $1.7T by 2035 at 16% CAGR
The Software Defined Vehicle (SDV) market is projected to expand from USD 447.55 billion in 2026 to USD 1,707.36 billion by 2035, growing at a compound annual growth rate (CAGR) of 16.0%. This growth is driven by the automotive industry's shift towar...

Brazilian health authority receives application for Bavarian Nordic's chikungunya vaccine approval
Bavarian Nordic's partner Eurofarma has submitted an application to Brazil's health authority Anvisa for approval of the chikungunya vaccine CHIKV VLP, targeting prevention in people aged 12 and above. This marks a key step in making the vaccine avai...

Bavarian Nordic’s chikungunya vaccine submitted for approval in Brazil, targeting a major outbreak region.
Bavarian Nordic's partner Eurofarma has submitted a regulatory approval application for the chikungunya vaccine CHIKV VLP to Brazil's health agency Anvisa. This marks a key step in making the vaccine available in Brazil, which reports over half of gl...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.